BDH Industries Ltd manufactures therapeutic formulations covering wide range of pharmaceuticalsBusiness Overview: BDHIL is a full-service Contract Manufacturing Organization for production of Pharmaceutical, Oncological Products and associated packaging services. It is an exporter and manufacturer of therapeutic formulations covering a wide range of pharmaceuticals
BDH Industries announced a special window for investors to transfer and dematerialize physical shares. This one-year period, established following a SEBI circular, is for physical securities bought or sold before April 2019, including those previously rejected due to document issues. Transferred shares will be credited in demat mode and subject...
BDH Industries has announced its financial results for the first quarter. For the quarter ended 30th June, 2026, the company reported a total income from operations of ₹22.82 Cr. Net profit after tax stood at ₹2.72 Cr, with Earnings Per Share (EPS) at ₹4.73. These results offer shareholders a clear...
BDH Industries' Board approved the financial results for the first quarter. These results, along with the Limited Review Report, will be published soon. Stay tuned for details.
BDH Industries has announced a board meeting on August 14, 2026, to consider its financial results for the first quarter. The company's trading window for securities remains closed until August 18.
BDH Industries has announced its 36th Annual General Meeting (AGM) will be held virtually on August 14, 2026, at 3:00 p.m. The company's Board has proposed a dividend of Rs. 5 per equity share for the financial year ended March 31, 2026, subject to shareholder approval. The record date for...
